EFFECTS OF ETHER LIPID O-OCTADECYL-2-METHOXY-RAC-GLYCERO-3-PHOSPHOCHOLINE AND ITS ANALOGS PAF AND CPAF ON THE RELEASE OF NITRIC-OXIDE IN PRIMARY CULTURES OF RAT ASTROCYTES

Citation
V. Cardile et al., EFFECTS OF ETHER LIPID O-OCTADECYL-2-METHOXY-RAC-GLYCERO-3-PHOSPHOCHOLINE AND ITS ANALOGS PAF AND CPAF ON THE RELEASE OF NITRIC-OXIDE IN PRIMARY CULTURES OF RAT ASTROCYTES, Brain research, 715(1-2), 1996, pp. 98-103
Citations number
52
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
00068993
Volume
715
Issue
1-2
Year of publication
1996
Pages
98 - 103
Database
ISI
SICI code
0006-8993(1996)715:1-2<98:EOELO>2.0.ZU;2-8
Abstract
Ether lipid octadecyl-2-O-methoxy-rac-glicero-3-phosphocholine (ET-18- OCH3) is an immunomodulator with antineoplastic activity. Its analog c ompounds PAF and CPAF share some of its biological effects. In our exp eriments, even very small amounts of ET-18-OCH3 released a remarkable quantity of nitric oxide (NO) from rat astrocytes cultured in vitro. T he NO biosynthesis was inhibited by pretreatment with the antagonist B N 50730. The effect of ET-18-OCH3 was greater than that of the LPS ind ucer. PAF did not produce NO, even at high doses, while the nonmetabol izable CPAF only induced a significant release of NO from 12 mu g/ml o nwards. These results demonstrate that ET-18-OCH3 is functionally acti ve also in astrocyte cultures. Stimulation of NO biosynthesis is of a great value on account of its the known effect as a neurotransmitter, potentiator of immune defences and possible modulator of cerebral circ ulation.